This inventor holds 3 USPTO granted patents. Top assignees: Les Laboratoires Servier, Les Laboratories Servier. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: Sandrine Pedragosa-Moreau: Innovator in Enzymatic Synthesis
Introduction
Sandrine Pedragosa-Moreau is a prominent inventor based in Orléans, France. She has made significant contributions to the field of enzymatic synthesis, particularly in the development of processes that aid in the pharmaceutical industry. With a total of 3 patents to her name, her work has garnered attention for its innovative approaches.
Latest Patents
Her latest patents include a process for the enzymatic synthesis of (7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or esters thereof, which has applications in the synthesis of ivabradine and its salts. Another notable patent involves the enzymatic synthesis of a compound of formula (I), where R represents a hydrogen atom or an alkyl group, also aimed at ivabradine synthesis. Additionally, she has developed a process for the enantioselective enzymatic hydrolysis of a specific nitrile, utilizing the nitrilase of EMBL accession number EF467367.1, further contributing to the synthesis of ivabradine and its addition salts.
Career Highlights
Throughout her career, Sandrine has worked with esteemed organizations such as Les Laboratoires Servier. Her expertise in enzymatic processes has positioned her as a valuable asset in the pharmaceutical sector, where her innovations continue to make an impact.
Collaborations
Some of her notable coworkers include François Lefoulon and Francisco Moris Varas. Their collaborative efforts have likely contributed to the advancements in the projects they have undertaken together.
Conclusion
Sandrine Pedragosa-Moreau's work in enzymatic synthesis exemplifies the innovative spirit of modern inventors. Her contributions to the field, particularly in the synthesis of ivabradine, highlight the importance of research and development in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

